Atossa Genetics Inc. (NASDAQ: ATOS) has announced that it has contracted with Rhenus Advanced Services B.V. to provide comprehensive logistics services and support in European markets.
Rhenus will provide Atossa with logistics services and support throughout European markets from its facilities located in Tilburg, the Netherlands, including warehousing, packaging, shipping, invoicing and collections. The Rhenus global operations include more than 390 locations and 24,000 employees worldwide.
Dr Steven C. Quay, chairman, CEO and president, stated, "Rhenus is one of the largest logistics firms in Europe and manages logistics operations for many of Europe’s leading medical device and healthcare companies. Contracting with Rhenus is a critical step in our European launch and we look forward to working with them as we commercialise our ForeCYTE Breast Aspirator device in select European markets."
A.J.L. van Erven, senior vice-president, Rhenus Contract Logistics Holding B.V., commented, "We are excited about Atossa Genetics and adding them to our expanding family of medical device manufacturers. We look forward to a rewarding business
relationship as we provide vital logistics and support services in the European markets and assist Atossa with the commercialisation of their innovative medical products."